[Clinical basis of provocative detoxicating etiotropic therapy of chronic toxoplasmosis in pediatric cases].
Clinical and laboratory data on the treatment of 19 children with chronic toxoplasmosis were used for estimation of the efficacy of drug combination, such as spiramycin + lidase and lincomycin + lidase vs. the traditional therapy (co-trimoxazole, metronidazole). The combination designed by us, i.e. spiramycin + lidase, lincomycin + lidase used in consecutive courses proved to be more efficient.